Autolus Therapeutics Plc ADR (AUTL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -287,528 | -220,662 | -208,383 | -148,839 | -142,096 |
| Depreciation Amortization | 9,814 | 7,716 | 6,565 | 7,422 | 8,458 |
| Income taxes - deferred | -286 | -185 | -986 | -268 | -72 |
| Accounts receivable | -24,158 | N/A | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | 1,300 | 1,590 | -509 | 22 | -1,816 |
| Other Working Capital | -51,989 | -23,655 | 292 | 536 | 4,138 |
| Other Operating Activity | 69,279 | 28,925 | 57,434 | 28,819 | 13,527 |
| Operating Cash Flow | $-283,568 | $-206,271 | $-145,587 | $-112,308 | $-117,861 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 185,590 | -359,733 | N/A | N/A | N/A |
| PPE Investments | -19,043 | -22,075 | -10,986 | -10,841 | -8,857 |
| Purchase Sale Intangibles | -8,089 | -12,744 | N/A | N/A | N/A |
| Other Investing Activity | -8,089 | -12,744 | 0 | 0 | 0 |
| Investing Cash Flow | $158,458 | $-394,552 | $-10,986 | $-10,841 | $-8,857 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | N/A | 550,579 | 27 | 163,971 | 246,025 |
| Other Financing Activity | -4,339 | 38,975 | -910 | 59,639 | 38,038 |
| Financing Cash Flow | $-4,339 | $589,554 | $-883 | $223,610 | $284,063 |
| Exchange Rate Effect | 6,279 | -261 | 15,030 | -28,376 | -754 |
| Beginning Cash Position | 228,805 | 240,335 | 382,761 | 310,676 | 154,085 |
| End Cash Position | 105,635 | 228,805 | 240,335 | 382,761 | 310,676 |
| Net Cash Flow | $-123,170 | $-11,530 | $-142,426 | $72,085 | $156,591 |
| Free Cash Flow | |||||
| Operating Cash Flow | -283,568 | -206,271 | -145,587 | -112,308 | -117,861 |
| Capital Expenditure | -19,043 | -22,075 | -10,986 | -10,841 | -8,857 |
| Free Cash Flow | -302,611 | -228,346 | -156,573 | -123,149 | -126,718 |